Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China flag China · Delayed Price · Currency is CNY
22.74
-0.03 (-0.13%)
Feb 3, 2026, 1:05 PM CST

SHE:002262 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,7831,4162,1591,5321,6081,402
Trading Asset Securities
2,1832,3731,3351,4521,058837
Cash & Short-Term Investments
3,9663,7893,4942,9842,6662,239
Cash Growth
3.13%8.46%17.08%11.94%19.05%13.06%
Accounts Receivable
1,6481,4961,054843.93720.49609.22
Other Receivables
76.6849.0741.8442.5227.6119.35
Receivables
1,7241,5451,095886.45748.09628.57
Inventory
880.81661.39628.64716.34604.33433.86
Prepaid Expenses
-5.45004.81-
Other Current Assets
77.5157.8436.6363.419.9617.73
Total Current Assets
6,6496,0605,2554,6504,0433,320
Property, Plant & Equipment
1,5711,6091,4961,3041,1581,034
Long-Term Investments
155.44125.31106.77118.61130.4181.23
Other Intangible Assets
227.48232.09190.47111.195.98101.04
Long-Term Deferred Tax Assets
43.0355.3958.3236.9530.6631.2
Long-Term Deferred Charges
314.75263.61128.03131.8880.5125.95
Other Long-Term Assets
119.2995.294.05128.51158.09155.18
Total Assets
9,0808,4407,3286,4815,6974,748
Accounts Payable
494.55568.35277.2255.74267.17165.19
Accrued Expenses
-180.54296.13297.3653.0938.73
Short-Term Debt
-1555303838
Current Portion of Leases
20.8220.1820.8620.6325.01-
Current Income Taxes Payable
181.3691.2884.183.580.8597.91
Current Unearned Revenue
28.0741.5326.4926.724.1141.07
Other Current Liabilities
187.39149.3754.2680.02193.72194.05
Total Current Liabilities
912.191,066814.03793.94681.96574.95
Long-Term Debt
0.230.230.230.230.230.23
Long-Term Leases
25.6833.8735.5641.9147.67-
Long-Term Unearned Revenue
41.4141.4153.8758.0563.667.77
Long-Term Deferred Tax Liabilities
-0.111.463.3--
Other Long-Term Liabilities
24.6424.6412.95---
Total Liabilities
1,0041,166918.09897.43793.45642.94
Common Stock
1,0161,0161,0081,0081,0081,008
Additional Paid-In Capital
277.35244.18102.99119.41119.4149.85
Retained Earnings
6,8786,1385,3174,4813,7833,086
Treasury Stock
-68.3-98.86----35.32
Comprehensive Income & Other
0.870.876.7513.110.9515.09
Total Common Equity
8,1047,3006,4345,6224,9214,123
Minority Interest
-28.33-26.81-24.03-37.79-16.96-17.5
Shareholders' Equity
8,0767,2746,4105,5844,9044,105
Total Liabilities & Equity
9,0808,4407,3286,4815,6974,748
Total Debt
46.7269.27111.6492.77110.9138.23
Net Cash (Debt)
3,9203,7203,3822,8912,5552,201
Net Cash Growth
5.03%9.99%16.98%13.16%16.08%13.31%
Net Cash Per Share
3.863.683.362.862.532.17
Filing Date Shares Outstanding
1,0161,0161,0081,0081,0081,008
Total Common Shares Outstanding
1,0161,0161,0081,0081,0081,008
Working Capital
5,7374,9934,4413,8563,3612,745
Book Value Per Share
7.987.186.395.584.884.09
Tangible Book Value
7,8767,0686,2445,5104,8254,022
Tangible Book Value Per Share
7.756.966.205.474.793.99
Buildings
-613.6599.08593.38569.55604.46
Machinery
-1,5461,3411,2511,088934.72
Construction In Progress
-309.38293.7692.0717.213.7
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.